1. Home
  2. AFG vs BMRN Comparison

AFG vs BMRN Comparison

Compare AFG & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Financial Group Inc.

AFG

American Financial Group Inc.

HOLD

Current Price

$132.49

Market Cap

11.6B

Sector

Finance

ML Signal

HOLD

Logo BioMarin Pharmaceutical Inc.

BMRN

BioMarin Pharmaceutical Inc.

HOLD

Current Price

$53.40

Market Cap

10.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AFG
BMRN
Founded
1872
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.6B
10.5B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
AFG
BMRN
Price
$132.49
$53.40
Analyst Decision
Hold
Buy
Analyst Count
3
19
Target Price
$131.00
$88.42
AVG Volume (30 Days)
433.2K
3.0M
Earning Date
11-04-2025
10-27-2025
Dividend Yield
2.66%
N/A
EPS Growth
N/A
59.53
EPS
9.52
2.68
Revenue
$8,011,000,000.00
$3,094,001,000.00
Revenue This Year
N/A
$13.39
Revenue Next Year
$4.91
$7.57
P/E Ratio
$13.92
$19.92
Revenue Growth
1.20
12.39
52 Week Low
$114.73
$50.76
52 Week High
$150.02
$73.51

Technical Indicators

Market Signals
Indicator
AFG
BMRN
Relative Strength Index (RSI) 39.99 46.19
Support Level $130.00 $53.03
Resistance Level $138.75 $54.66
Average True Range (ATR) 2.61 1.45
MACD -0.76 -0.11
Stochastic Oscillator 22.57 31.61

Price Performance

Historical Comparison
AFG
BMRN

About AFG American Financial Group Inc.

American Financial Group Inc is a holding company that is engaged in property and casualty insurance services. The company has a focus on specialized commercial products for businesses. The Company operates through two segments: Property & Casualty Insurance and Other. The Property & Casualty segment includes Property & Transportation, covering buses, trucks, marine, agriculture, and commercial property; Specialty Casualty, offering excess & surplus, liability, and professional insurance; and Specialty Financial, providing risk management for lending and leasing institutions, fidelity and surety products, and trade credit insurance. The company's insurance operations are conducted through the Great American Insurance Group.

About BMRN BioMarin Pharmaceutical Inc.

BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.

Share on Social Networks: